Style
Aggressive GrowthTurnover
Orientation
Concentrated long-term| # | Security | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | Bridgebio Pharma Inc(BBIO) | 4,589,611 | $341.8M | 72.48% |
| 2 | Monte Rosa Therapeutics Inc(GLUE) | 1,555,664 | $37.6M | 7.98% |
| 3 | Syndax Pharmaceuticals Inc(SNDX) | 1,316,806 | $28.8M | 6.10% |
| 4 | Compass Pathways PLC(CMPS) | 1,432,336 | $20.3M | 4.30% |
| 5 | Bicara Therapeutics Inc(BCAX) | 568,919 | $16.9M | 3.58% |
Latest filing, equity positions only
Quarter-over-quarter weight changes
| Sector | Prev % | Curr % | Change |
|---|---|---|---|
| Healthcare | 99.59% | 99.16% | -0.43% |
| Unclassified | 0.41% | 0.84% | +0.43% |
Quarter-over-quarter weight changes by market cap
| 6 |
| Bridgebio Oncology Therapeut(BBOT) |
| 1,018,018 |
| $7.8M |
| 1.64% |
| 7 | Scholar Rock Hldg Corp(SRRK) | 77,031 | $4.2M | 0.90% |
| 8 | Urogen Pharma LTD(URGN) | 108,000 | $4.0M | 0.84% |
| 9 | Biomea Fusion Inc(BMEA) | 2,048,757 | $3.0M | 0.64% |
| 10 | Aclaris Therapeutics Inc(ACRS) | 434,455 | $2.3M | 0.49% |
| Cap Size | Prev % | Curr % | Change |
|---|---|---|---|
| Large Cap | 79.35% | 72.48% | -6.87% |
| Small Cap | 12.16% | 18.45% | +6.29% |
| Mid Cap | 7.25% | 7% | -0.25% |
| Micro Cap | 0.82% | 1.22% | +0.4% |
| Unclassified | 0.41% | 0.84% | +0.43% |
Quarter-over-quarter position changes